390 related articles for article (PubMed ID: 9442040)
21. ADP-induced platelet shape change: an investigation of the signalling pathways involved and their dependence on the method of platelet preparation.
Wilde JI; Retzer M; Siess W; Watson SP
Platelets; 2000 Aug; 11(5):286-95. PubMed ID: 11030463
[TBL] [Abstract][Full Text] [Related]
22. The P2Y1 receptor mediates ADP-induced p38 kinase-activating factor generation in human platelets.
Dangelmaier C; Jin J; Daniel JL; Smith JB; Kunapuli SP
Eur J Biochem; 2000 Apr; 267(8):2283-9. PubMed ID: 10759852
[TBL] [Abstract][Full Text] [Related]
23. Both the ADP receptors P2Y1 and P2Y12, play a role in controlling shape change in human platelets.
Jagroop IA; Burnstock G; Mikhailidis DP
Platelets; 2003 Feb; 14(1):15-20. PubMed ID: 12623443
[TBL] [Abstract][Full Text] [Related]
24. The P2 receptors and congenital platelet function defects.
Cattaneo M
Semin Thromb Hemost; 2005 Apr; 31(2):168-73. PubMed ID: 15852220
[TBL] [Abstract][Full Text] [Related]
25. Thrombopoietin complements G(i)- but not G(q)-dependent pathways for integrin {alpha}(IIb){beta}(3) activation and platelet aggregation.
Campus F; Lova P; Bertoni A; Sinigaglia F; Balduini C; Torti M
J Biol Chem; 2005 Jul; 280(26):24386-95. PubMed ID: 15863506
[TBL] [Abstract][Full Text] [Related]
26. The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells.
Léon C; Hechler B; Vial C; Leray C; Cazenave JP; Gachet C
FEBS Lett; 1997 Feb; 403(1):26-30. PubMed ID: 9038354
[TBL] [Abstract][Full Text] [Related]
27. The ATP-gated P2X1 ion channel acts as a positive regulator of platelet responses to collagen.
Oury C; Toth-Zsamboki E; Thys C; Tytgat J; Vermylen J; Hoylaerts MF
Thromb Haemost; 2001 Nov; 86(5):1264-71. PubMed ID: 11816716
[TBL] [Abstract][Full Text] [Related]
28. The P2Y1 receptor is normal in a patient presenting a severe deficiency of ADP-induced platelet aggregation.
Léon C; Vial C; Gachet C; Ohlmann P; Hechler B; Cazenave JP; Lecchi A; Cattaneo M
Thromb Haemost; 1999 May; 81(5):775-81. PubMed ID: 10365753
[TBL] [Abstract][Full Text] [Related]
29. The role of ADP receptors in platelet function.
Murugappa S; Kunapuli SP
Front Biosci; 2006 May; 11():1977-86. PubMed ID: 16368572
[TBL] [Abstract][Full Text] [Related]
30. Role of intracellular signaling events in ADP-induced platelet aggregation.
Daniel JL; Dangelmaier C; Jin J; Kim YB; Kunapuli SP
Thromb Haemost; 1999 Oct; 82(4):1322-6. PubMed ID: 10544922
[TBL] [Abstract][Full Text] [Related]
31. Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation.
Jantzen HM; Gousset L; Bhaskar V; Vincent D; Tai A; Reynolds EE; Conley PB
Thromb Haemost; 1999 Jan; 81(1):111-7. PubMed ID: 10348701
[TBL] [Abstract][Full Text] [Related]
32. Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog.
Chhatriwala M; Ravi RG; Patel RI; Boyer JL; Jacobson KA; Harden TK
J Pharmacol Exp Ther; 2004 Dec; 311(3):1038-43. PubMed ID: 15345752
[TBL] [Abstract][Full Text] [Related]
33. (N)-methanocarba-2MeSADP (MRS2365) is a subtype-specific agonist that induces rapid desensitization of the P2Y1 receptor of human platelets.
Bourdon DM; Mahanty SK; Jacobson KA; Boyer JL; Harden TK
J Thromb Haemost; 2006 Apr; 4(4):861-8. PubMed ID: 16634757
[TBL] [Abstract][Full Text] [Related]
34. The C6-2B glioma cell P2Y(AC) receptor is pharmacologically and molecularly identical to the platelet P2Y(12) receptor.
Jin J; Tomlinson W; Kirk IP; Kim YB; Humphries RG; Kunapuli SP
Br J Pharmacol; 2001 Jun; 133(4):521-8. PubMed ID: 11399669
[TBL] [Abstract][Full Text] [Related]
35. The plaque lipid lysophosphatidic acid stimulates platelet activation and platelet-monocyte aggregate formation in whole blood: involvement of P2Y1 and P2Y12 receptors.
Haserück N; Erl W; Pandey D; Tigyi G; Ohlmann P; Ravanat C; Gachet C; Siess W
Blood; 2004 Apr; 103(7):2585-92. PubMed ID: 14645014
[TBL] [Abstract][Full Text] [Related]
36. Activity of adenosine diphosphates and triphosphates on a P2Y(T) -type receptor in brain capillary endothelial cells.
Simon J; Vigne P; Eklund KM; Michel AD; Carruthers AM; Humphrey PP; Frelin C; Barnard EA
Br J Pharmacol; 2001 Jan; 132(1):173-82. PubMed ID: 11156575
[TBL] [Abstract][Full Text] [Related]
37. Effect of clopidogrel administration to healthy volunteers on platelet phosphorylation events triggered by ADP.
Contreres JO; Dupuy E; Job B; Habib A; Bryckaert M; Rosa JP; Simoneau G; Herbert JM; Savi P; Levy-Toledano S
Br J Haematol; 2003 Feb; 120(4):633-42. PubMed ID: 12588350
[TBL] [Abstract][Full Text] [Related]
38. Antiplatelet action of R-99224, an active metabolite of a novel thienopyridine-type G(i)-linked P2T antagonist, CS-747.
Sugidachi A; Asai F; Yoneda K; Iwamura R; Ogawa T; Otsuguro K; Koike H
Br J Pharmacol; 2001 Jan; 132(1):47-54. PubMed ID: 11156560
[TBL] [Abstract][Full Text] [Related]
39. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation.
Jin J; Kunapuli SP
Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8070-4. PubMed ID: 9653141
[TBL] [Abstract][Full Text] [Related]
40. Platelet shape change evoked by selective activation of P2X1 purinoceptors with alpha,beta-methylene ATP.
Rolf MG; Brearley CA; Mahaut-Smith MP
Thromb Haemost; 2001 Feb; 85(2):303-8. PubMed ID: 11246552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
